BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30269224)

  • 1. The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study.
    Idris I; Peng X; He X; Liu D; Balogh E; Kaushik P; Van Brunt K
    Diabetes Ther; 2018 Dec; 9(6):2245-2257. PubMed ID: 30269224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009-2020.
    Hankosky ER; Schapiro D; Gunn KB; Lubelczyk EB; Mitroi J; Nelson DR
    Diabetes Ther; 2023 Jun; 14(6):967-975. PubMed ID: 37067668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS).
    Ramachandran A; Jain SM; Mukherjee S; Phatak S; Pitale S; Singh SK; Agrawal N; Majumdar A; Deshpande N; Jhulka S; Minakshisundaram S; Chawla M; Lodha S; Maheshwari A; Makkar BM; Rao S; Shah P; Ghosh R; Mohanasundaram S; Menon S; Chodankar D; Kanade V; Trivedi C
    Ther Adv Endocrinol Metab; 2020; 11():2042018820937217. PubMed ID: 32647562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin.
    van Brunt K; Curtis B; Ivanyi T; Balogh E; Chalkiadaki C; MacLachlan S; Neasham D; Raluy-Callado M
    Diabetes Ther; 2016 Dec; 7(4):793-807. PubMed ID: 27796906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study.
    Zhong VW; Juhaeri J; Mayer-Davis EJ
    Diabetes Care; 2018 Sep; 41(9):1870-1877. PubMed ID: 29386248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM).
    Brož J; Janíčková Žďárská D; Urbanová J; Brabec M; Doničová V; Štěpánová R; Martinka E; Kvapil M
    Diabetes Ther; 2018 Oct; 9(5):1897-1906. PubMed ID: 30094784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonality of Insulin Use in German Outpatients With Diabetes: A Retrospective Analysis.
    Kostev K; Gläser S; Jacob L
    J Diabetes Sci Technol; 2017 Sep; 11(5):996-1000. PubMed ID: 28420259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response.
    Gu T; Hong T; Zhang P; Tang S; Bi Y; Lu H; Men L; Ma D; Zhu D
    Diabetes Ther; 2018 Apr; 9(2):771-787. PubMed ID: 29524190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BrazIliaN Type 1 & 2 DiabetEs Disease Registry (BINDER): longitudinal, real-world study of diabetes mellitus control in Brazil.
    de Almeida-Pititto B; Eliaschewitz FG; de Paula MA; Ferreira GC
    Front Clin Diabetes Healthc; 2022; 3():934629. PubMed ID: 36992732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
    Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R
    Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' empowerment, physicians' perceptions, and achievement of therapeutic goals in patients with type 1 and type 2 diabetes mellitus in Mexico.
    Lavalle-González FJ; Chiquete E
    Patient Prefer Adherence; 2016; 10():1349-57. PubMed ID: 27555751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pregnancy on insulin requirements differs between type 1 and type 2 diabetes: A cohort study of 222 pregnancies.
    Padmanabhan S; Jiang S; Mclean M; Cheung NW
    Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):352-7. PubMed ID: 26852894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between Self-Management and Glycemic Control in a Cohort of Children with Type 1 and Type 2 Diabetes.
    Rodriguez LM; Hassan KV; Rhodes J; McKay SV; Heptulla RA
    J Diabetes Metab; 2013 Dec; 4():. PubMed ID: 25258699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes.
    Suzuki K; Mitsuma Y; Sato T; Anraku T; Hatta M
    J Clin Med Res; 2016 Nov; 8(11):805-814. PubMed ID: 27738482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.
    Candido R; Wyne K; Romoli E
    Diabetes Ther; 2018 Jun; 9(3):927-949. PubMed ID: 29654514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.
    Bae JP; Lage MJ; Mo D; Nelson DR; Hoogwerf BJ
    J Diabetes Complications; 2016 Mar; 30(2):212-20. PubMed ID: 26689451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.